Item Type | Name |
Concept
|
Inflammatory Bowel Diseases
|
Academic Article
|
Smoking and inflammatory bowel disease.
|
Academic Article
|
The changing face of colorectal cancer in inflammatory bowel disease: progress at last!
|
Academic Article
|
Colorectal cancer in inflammatory bowel disease: molecular and clinical considerations.
|
Academic Article
|
Surveillance for cancer and dysplasia in inflammatory bowel disease.
|
Academic Article
|
Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership.
|
Academic Article
|
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.
|
Academic Article
|
Quality of care in inflammatory bowel disease: a review and discussion.
|
Academic Article
|
Novel diagnostic and prognostic modalities in inflammatory bowel disease.
|
Academic Article
|
Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
|
Academic Article
|
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
|
Academic Article
|
Colorectal cancer and dysplasia in inflammatory bowel disease.
|
Academic Article
|
Infectious proctitis: when to suspect it is not inflammatory bowel disease.
|
Academic Article
|
Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.
|
Academic Article
|
Do patients with inflammatory bowel disease want genetic testing?
|
Academic Article
|
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
|
Academic Article
|
The complexity and challenges of genetic counseling and testing for inflammatory bowel disease.
|
Academic Article
|
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
|
Academic Article
|
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.
|
Academic Article
|
Role of antibiotics in the management of inflammatory bowel disease: a review.
|
Academic Article
|
An updated approach to dysplasia in IBD.
|
Academic Article
|
Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members.
|
Academic Article
|
Novel diagnostic and prognostic modalities in inflammatory bowel disease.
|
Academic Article
|
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
Academic Article
|
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
|
Academic Article
|
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
|
Academic Article
|
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
|
Academic Article
|
Fecal microbiota transplantation: an interest in IBD?
|
Academic Article
|
Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.
|
Academic Article
|
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
|
Academic Article
|
Why it's time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease.
|
Academic Article
|
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
|
Academic Article
|
Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients.
|
Academic Article
|
The rationale and growth of advanced training in inflammatory bowel disease.
|
Academic Article
|
Can we improve on the "see one, do one, teach one" paradigm in training fellows to care for patients with inflammatory bowel disease?
|
Academic Article
|
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
|
Academic Article
|
Ethical considerations for clinical trials in inflammatory bowel disease.
|
Academic Article
|
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.
|
Academic Article
|
Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
|
Academic Article
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
|
Academic Article
|
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease.
|
Academic Article
|
Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
|
Academic Article
|
When Should Therapy for Inflammatory Bowel Disease Be Stopped?
|
Academic Article
|
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
|
Academic Article
|
Activation of the Renin-Angiotensin System Promotes Colitis Development.
|
Academic Article
|
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease.
|
Academic Article
|
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.
|
Academic Article
|
A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.
|
Academic Article
|
Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
|
Academic Article
|
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
|
Academic Article
|
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
|
Academic Article
|
The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
|
Academic Article
|
The Role of Biosimilars in Inflammatory Bowel Disease.
|
Academic Article
|
The Rationale and Growth of Advanced Training in Inflammatory Bowel Disease.
|
Academic Article
|
The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
|
Academic Article
|
Inflammatory Bowel Disease and Cerebral Venous Sinus Thrombosis.
|
Academic Article
|
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
|
Academic Article
|
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
|
Academic Article
|
Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
Academic Article
|
Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion.
|
Academic Article
|
Emerging Therapies for Inflammatory Bowel Disease.
|
Academic Article
|
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
Academic Article
|
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
|
Academic Article
|
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
|
Academic Article
|
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
|
Academic Article
|
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
|
Academic Article
|
Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
|
Academic Article
|
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
|
Academic Article
|
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
|
Academic Article
|
The use of tofacitinib in the treatment of inflammatory bowel disease.
|
Academic Article
|
Recent Research on Joint Pain and Arthritis in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
|
Academic Article
|
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
|
Academic Article
|
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
|
Academic Article
|
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Histologic Remission in Ulcerative Colitis: Are We There Yet?
|
Academic Article
|
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
|
Academic Article
|
Challenges in IBD Research: Pragmatic Clinical Research.
|
Academic Article
|
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
|
Academic Article
|
Proposal to Update the Curriculum in Inflammatory Bowel Diseases for Categorical Gastroenterology Fellows.
|
Academic Article
|
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
|
Academic Article
|
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
|
Academic Article
|
Treatment De-Escalation in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
|
Academic Article
|
Inpatient Management of Inflammatory Bowel Disease-Related Complications.
|
Academic Article
|
Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
|
Academic Article
|
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.
|
Academic Article
|
Practical advice for management of inflammatory bowel diseases patients during the COVID-19 pandemic: World Endoscopy Organization Statement.
|
Academic Article
|
Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
|
Academic Article
|
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
|
Academic Article
|
Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act.
|
Academic Article
|
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
|
Academic Article
|
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
|
Academic Article
|
Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
|
Academic Article
|
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI.
|
Academic Article
|
Emerging treatment options for extraintestinal manifestations in IBD.
|
Academic Article
|
Long-term safety of vedolizumab for inflammatory bowel disease.
|
Academic Article
|
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
|
Academic Article
|
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
|
Academic Article
|
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
|
Academic Article
|
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
|
Academic Article
|
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment.
|
Academic Article
|
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
|
Academic Article
|
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
|
Academic Article
|
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
|
Academic Article
|
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
|
Academic Article
|
Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes.
|
Academic Article
|
Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery.
|
Academic Article
|
Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease.
|
Academic Article
|
Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
|
Academic Article
|
Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
|
Academic Article
|
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.
|
Academic Article
|
New targets in inflammatory bowel disease therapy: 2021.
|
Academic Article
|
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.
|
Academic Article
|
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
Academic Article
|
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
|
Academic Article
|
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
|
Academic Article
|
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.
|
Academic Article
|
Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
|
Academic Article
|
Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls.
|
Academic Article
|
CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
|
Academic Article
|
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
|
Academic Article
|
Entering the Era of Disease Modification in Inflammatory Bowel Disease.
|
Academic Article
|
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
|
Academic Article
|
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease.
|
Academic Article
|
Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement.
|
Academic Article
|
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget.
|
Academic Article
|
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.
|
Academic Article
|
Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.
|
Academic Article
|
IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
|
Academic Article
|
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
Academic Article
|
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
|
Academic Article
|
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries.
|
Academic Article
|
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.
|
Academic Article
|
Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease.
|
Academic Article
|
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
|
Academic Article
|
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes.
|
Academic Article
|
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
|
Academic Article
|
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
|
Academic Article
|
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
Academic Article
|
Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.
|
Academic Article
|
Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications.
|
Academic Article
|
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
|
Academic Article
|
Transmural Healing in Inflammatory Bowel Disease.
|
Academic Article
|
Intestinal Ultrasound in the Assessment and Management of Inflammatory Bowel Disease: Is It Ready for Standard Practice?
|
Academic Article
|
Role and Impact of a Clinical Pharmacy Team at an Inflammatory Bowel Disease Center.
|
Academic Article
|
Ultrasonographic Transmural Healing in Crohn's Disease.
|
Academic Article
|
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21).
|
Academic Article
|
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.
|
Academic Article
|
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
|
Academic Article
|
The Arrival of Intestinal Ultrasound for Inflammatory Bowel Disease Care in the United States.
|
Academic Article
|
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.
|
Academic Article
|
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus.
|
Academic Article
|
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
|
Academic Article
|
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD.
|
Academic Article
|
Common Instances of Low-value Care in Inflammatory Bowel Diseases.
|
Academic Article
|
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
|
Academic Article
|
Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol.
|
Academic Article
|
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience.
|
Academic Article
|
Clinical Application of Intestinal Ultrasound in Inflammatory Bowel Disease.
|
Academic Article
|
Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
|
Academic Article
|
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease.
|
Academic Article
|
Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device.
|